Senior Vice President of Pharmaceutical Development

Dr. Charles Evans serves as Senior Vice President of Pharmaceutical Development at MedPharm, with more than 20 years of experience in advancing products from early-phase through to commercialisation across topical, inhalation, transdermal, and injectable platforms. He has particular expertise in complex delivery systems designed to optimise drug efficacy, quality, and safety.

Throughout his career, Dr. Evans has led multidisciplinary teams in the design and optimisation of a broad range of dosage forms, including liquids, semi-solids, aerosols, and transdermal patches. He played a pivotal role in developing MedPharm’s proprietary MedSpray® technology, now licensed to enhance client product performance.

In his current role, he oversees global product development strategy and leads MedPharm’s UK centre of excellence for formulation development. Dr. Evans drives the delivery of robust, effective drug products, covering the full development lifecycle—from early formulation to scale-up and manufacturing—supported by a strong foundation in regulatory compliance and scientific rigour. His leadership helped establish MedPharm’s reputation for excellence in topical and transdermal drug delivery. He continues to contribute to the field through publications, patents, and active industry engagement.

Dr. Evans holds a PhD in Pharmacy from the University of Hertfordshire in the UK, where his research focused on novel spray-based treatments for dermatological conditions and MedPharm’s MedSpray® system.